clinical trial · NCT05068388
Effect of Oral (Z)-Endoxifen in Premenopausal Women With Measurable Breast Density
Breast DensityZ-EndoxifenPlacebo
brief summary
This is a randomized, double-blinded, placebo-controlled dose-response efficacy study of oral (Z)-endoxifen in premenopausal women with measurable breast density. There will be 5 in-clinic visits (Screening, Day 1, Months 1, 3 and 6) and 3 self-report visits (Months 2, 4 and 5). Standard of care mammograms will be used for the screening mammogram as well as the 24-month follow up visit.
started
Dec 21, 2021
primary completion
Aug 28, 2024
completion
Dec 31, 2025
last updated
Apr 26, 2024
official title
A Phase 2, Randomized, Double-blinded, Placebo-controlled, Dose-Response Study of Oral (Z)-Endoxifen in Premenopausal Women With Measurable Breast Density
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol